Design, synthesis, and evaluation of conformationally constrained tongs, new inhibitors of HIV-1 protease dimerization

被引:56
作者
Bouras, A
Boggetto, N
Benatalah, Z
de Rosny, E
Sicsic, S
Reboud-Ravaux, M
机构
[1] Univ Paris Sud, Fac Pharm, CNRS, URA 1843,BIOCIS, F-92296 Chatenay Malabry, France
[2] Univ Paris 06, Inst Jacques Monod, Lab Enzymol Mol & Fonct, Dept Biol Supramol & Cellulaire, F-75251 Paris 05, France
[3] Univ Paris 07, Inst Jacques Monod, Lab Enzymol Mol & Fonct, Dept Biol Supramol & Cellulaire, F-75251 Paris 05, France
关键词
D O I
10.1021/jm9803976
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The active form of human immunodeficiency virus type 1 protease (HIV-1 PR) is a homodimeric structure in which two subunits are linked through a two-stranded antiparallel beta-sheet consisting of the N- and C-termini of each monomer. To inhibit the dimerization process or disrupt the dimeric interface leading to inactive enzyme, conformationally constrained "molecular tongs" have been designed and synthesized to interfere with one monomer end in a P-sheet fashion. These molecules are based on two peptidic strands attached to an aromatic scaffold. Inhibitions (submicromolar range) were obtained with molecular tongs containing tripeptidic or tetrapeptidic arms attached to a pyridinediol- or naphthalenediol-based scaffold (K-id = 0.56-4.5 mu M at pH 4.7 and 30 degrees C). Kinetic studies are in agreement with an interface inhibition mechanism.
引用
收藏
页码:957 / 962
页数:6
相关论文
共 17 条
[1]  
ARNOLD G, 1994, PEPTIDES 1994, P345
[2]   INHIBITION OF HIV PROTEASE ACTIVITY BY HETERODIMER FORMATION [J].
BABE, LM ;
PICHUANTES, S ;
CRAIK, CS .
BIOCHEMISTRY, 1991, 30 (01) :106-111
[3]   SYNTHETIC INTERFACE PEPTIDES ALTER DIMERIC ASSEMBLY OF THE HIV-1 AND HIV-2 PROTEASES [J].
BABE, LM ;
ROSE, J ;
CRAIK, CS .
PROTEIN SCIENCE, 1992, 1 (10) :1244-1253
[4]   PURIFICATION, ASSAY AND KINETIC FEATURES OF HIV-1 PROTEINASE [J].
BILLICH, A ;
HAMMERSCHMID, F ;
WINKLER, G .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (03) :265-272
[5]   A SYSTEMATIC EVALUATION OF THE INHIBITION OF HIV-1 PROTEASE BY ITS C-TERMINAL AND N-TERMINAL PEPTIDES [J].
FRANCISKOVICH, J ;
HOUSEMAN, K ;
MUELLER, R ;
CHMIELEWSKI, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (04) :765-768
[6]   ACTIVE HUMAN IMMUNODEFICIENCY VIRUS PROTEASE IS REQUIRED FOR VIRAL INFECTIVITY [J].
KOHL, NE ;
EMINI, EA ;
SCHLEIF, WA ;
DAVIS, LJ ;
HEIMBACH, JC ;
DIXON, RAF ;
SCOLNICK, EM ;
SIGAL, IS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4686-4690
[7]   PEPTIDOMIMETIC HOST THAT BINDS A PEPTIDE GUEST AFFORDING A BETA-SHEET STRUCTURE THAT SUBSEQUENTLY SELF-ASSEMBLES - A SIMPLE RECEPTOR MIMIC [J].
LABRENZ, SR ;
KELLY, JW .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (05) :1655-1656
[8]   X-RAY-ANALYSIS OF HIV-1 PROTEINASE AT 2.7 A RESOLUTION CONFIRMS STRUCTURAL HOMOLOGY AMONG RETROVIRAL ENZYMES [J].
LAPATTO, R ;
BLUNDELL, T ;
HEMMINGS, A ;
OVERINGTON, J ;
WILDERSPIN, A ;
WOOD, S ;
MERSON, JR ;
WHITTLE, PJ ;
DANLEY, DE ;
GEOGHEGAN, KF ;
HAWRYLIK, SJ ;
LEE, SE ;
SCHELD, KG ;
HOBART, PM .
NATURE, 1989, 342 (6247) :299-302
[9]   NOVEL FLUOROGENIC SUBSTRATES FOR ASSAYING RETROVIRAL PROTEASES BY RESONANCE ENERGY-TRANSFER [J].
MATAYOSHI, ED ;
WANG, GT ;
KRAFFT, GA ;
ERICKSON, J .
SCIENCE, 1990, 247 (4945) :954-958
[10]   3-DIMENSIONAL STRUCTURE OF ASPARTYL PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS HIV-1 [J].
NAVIA, MA ;
FITZGERALD, PMD ;
MCKEEVER, BM ;
LEU, CT ;
HEIMBACH, JC ;
HERBER, WK ;
SIGAL, IS ;
DARKE, PL ;
SPRINGER, JP .
NATURE, 1989, 337 (6208) :615-620